Pacific Biosciences of California, Inc. (PACB)
1.285
-0.06
(-4.81%)
USD |
NASDAQ |
Aug 24, 16:00
1.33
+0.04
(+3.50%)
After-Hours: 20:00
Pacific Biosciences of California Enterprise Value : 888.81M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 888.81M |
| August 20, 2026 | 851.52M |
| August 19, 2026 | 863.95M |
| August 18, 2026 | 823.54M |
| August 17, 2026 | 845.30M |
| August 14, 2026 | 826.65M |
| August 13, 2026 | 826.65M |
| August 12, 2026 | 814.22M |
| August 11, 2026 | 823.54M |
| August 10, 2026 | 826.65M |
| August 07, 2026 | 837.53M |
| August 06, 2026 | 831.31M |
| August 05, 2026 | 873.27M |
| August 04, 2026 | 916.79M |
| August 03, 2026 | 910.57M |
| July 31, 2026 | 904.36M |
| July 30, 2026 | 929.22M |
| July 29, 2026 | 904.36M |
| July 28, 2026 | 901.25M |
| July 27, 2026 | 891.92M |
| July 24, 2026 | 891.92M |
| July 23, 2026 | 904.36M |
| July 22, 2026 | 898.14M |
| July 21, 2026 | 904.36M |
| July 20, 2026 | 891.92M |
| Date | Value |
|---|---|
| July 17, 2026 | 916.79M |
| July 16, 2026 | 932.33M |
| July 15, 2026 | 944.76M |
| July 14, 2026 | 935.44M |
| July 13, 2026 | 932.33M |
| July 10, 2026 | 954.08M |
| July 09, 2026 | 969.63M |
| July 08, 2026 | 935.44M |
| July 07, 2026 | 954.08M |
| July 06, 2026 | 985.17M |
| July 02, 2026 | 991.38M |
| July 01, 2026 | 1.010B |
| June 30, 2026 | 991.38M |
| June 29, 2026 | 964.55M |
| June 26, 2026 | 939.71M |
| June 25, 2026 | 924.19M |
| June 24, 2026 | 874.51M |
| June 23, 2026 | 834.14M |
| June 22, 2026 | 837.25M |
| June 18, 2026 | 862.09M |
| June 17, 2026 | 843.46M |
| June 16, 2026 | 846.56M |
| June 15, 2026 | 837.25M |
| June 12, 2026 | 834.14M |
| June 11, 2026 | 846.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 34.49B |
| Agilent Technologies, Inc. | 46.42B |
| Bio-Rad Laboratories, Inc. | 9.912B |
| Danaher Corp. | 177.35B |
| Thermo Fisher Scientific, Inc. | 271.27B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.74M |
| Revenue (Quarterly) | 39.01M |
| Total Expenses (Quarterly) | 83.75M |
| EPS Diluted (Quarterly) | -0.144 |
| Gross Profit Margin (Quarterly) | 30.26% |
| Profit Margin (Quarterly) | -114.7% |
| Earnings Yield | -33.55% |
| Normalized Earnings Yield | -30.54 |